A new independent evaluation report from the Department of Health and Human Services showed that the Pioneer Accountable Care Organization (ACO) payment model has generated substantial savings to Medicare in just two years. Additionally, the independent Office of the Actuary in the Centers for Medicare & Medicaid Services (CMS) has certified that this patient care model is the first to meet the stringent criteria for expansion to a larger population of Medicare beneficiaries.

Pressure to create alternative payment models has led to a significant increase in provider interest in partnering with Premier Inc. to develop and implement population health management strategies.

Cath lab, cath lab management with multiple speciality users, EP, cardiology, IR, endovascular procedures

Most community hospitals with cardiac catheterization labs share these facilities with multiple, non-interventional cardiology users, which can be challenging to manage various specialties’ needs. Beyond percutaneous coronary interventions (PCI), these labs are frequently shared with electrophysiologists (EP), vascular surgeons conducting endovascular repairs and interventional radiologists  (IR) performing an array of non-coronary vascular or peripheral interventions. 

Fujifilm Medical Systems U.S.A. said it completed its acquisition of TeraMedica Inc., a global healthcare informatics company and a provider of vendor neutral, enterprise solutions. The acquisition will allow Fujifilm to offer the market a leading vendor neutral archiving (VNA) technology.

At Nebraska Medicine, technology innovations bring with them opportunities to enhance patient care. The ability to integrate patient images with synchronized and simultaneous audio and video has Nebraska Medicine’s telehealth coordinator Kyle Hall looking at new ways to implement telehealth and mobile devices, such as iPads and Google Glass, at clinics and hospitals.

Abbott and GE Healthcare announced an agreement that will bring real-time, patient-specific data about the heart's electrical activity to cardiac electrophysiology labs. The goal of the collaboration is to speed up the diagnosis of the sources of atrial fibrillation and other heart rhythm disorders.

A team from Stanford University School of Medicine has developed and combined new paper and flexible polymer substrates with special sensing devices for rapid and accurate detection of pathogens such as HIV and other biotargets. These novel technologies offer the type of robust, simple, and inexpensive biosensing systems required to provide point-of-care healthcare in remote areas, where there is minimal diagnostic infrastructure or equipment and a lack of trained medical technicians.

Cardiovascular Systems Inc. (CSI) featured two-year data from its ORBIT II study of the company’s Diamondback 360 coronary orbital atherectomy system (OAS) in a late-breaking presentation at the 2015 Society for Cardiovascular Angiography and Interventions (SCAI) conference. Diamondback 360 is a U.S. Food and Drug Administration (FDA)-approved atherectomy technology indicated for the treatment of severely calcified lesions.

CardiAQ Valve Technologies announced U.S. Food and Drug Administration (FDA) Investigational Device Exemption (IDE) approval for a feasibility study of its second generation transfemoral (TF) and transapical (TA) transcatheter mitral valve implantation systems. The study will enroll up to 20 patients (10 TF and 10 TA) and multidisciplinary physician teams at select U.S. sites will start enrollment once hospital approvals and agreements are in place.

Subscribe to
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now